Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

OBJECTIVES: This is the first clinical trial of this type in Japan, designed to analyze two important aspects of Alzheimer’s disease (AD) management using medium-chain triglycerides. Axona was administered for 3 months (40 g of powder containing 20 g of caprylic triglycerides). We used an indurating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Interv Aging
Hauptverfasser: Ohnuma, Tohru, Toda, Aiko, Kimoto, Ayako, Takebayashi, Yuto, Higashiyama, Ryoko, Tagata, Yuko, Ito, Masanobu, Ota, Tsuneyoshi, Shibata, Nobuto, Arai, Heii
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712972/
https://ncbi.nlm.nih.gov/pubmed/26811674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S95362
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge